欧洲疾控中心-呼吸道病毒综合监测报告方案（英）-2025.12_98页_1mb

AI报告摘要

Reporting Protocol Summary - 2025 Version

Core Content Overview

This document outlines the updated reporting protocol for integrated respiratory virus surveillance in the EU/EEA and wider WHO European Region. It provides guidelines for data preparation, submission, and validation for various record types, with a focus on influenza, SARS-CoV-2, and respiratory syncytial virus (RSV) surveillance.

Main Objectives

Monitor intensity, geographical spread, and temporal patterns of respiratory virus infections to inform mitigation measures.
Monitor severity and risk factors for severe disease and assess the impact on healthcare systems.
Track changes and characteristics of circulating and emerging respiratory viruses to guide treatment, drug, and vaccine development.
Describe disease burden associated with respiratory infections.
Assess vaccine effectiveness where feasible.

Key Changes in Metadata

SARISURV

12/12/2025: RSVVacProduct updated to include monoclonal antibodies; Drug Used for Prophylaxis updated.
21/05/2025: Drug Used for Prophylaxis and Drug Used for Treatment updated.
27/11/2023: BA.2.86 added to VirusVariantCOVID.
29/07/2024: KP.3 added to VirusVariantCOVID.
Precondition and Complications added as repeatable variables with updated coded value lists (DOWNS and PREM included).
OtherSymptoms changed to repeatable with coded value list.
ResultSARSCoV2 added, replacing ResultPCRSARSCoV2 and ResultRADTSARSCoV2.
Removed variables: PreviousInfluenza, WgsEnaId, and several resistance mutation fields.

INFLSARIAGGR

Added unknown age cases for SARI admissions, deaths, and tests.
Removed total cases variables and renamed some test counts.
Removed NumSpecimensSWOAH1DetectSARI and NumSpecimensSWOAH1N1DetectSARI to NumSpecimensAH1pdm09DetectSARI and NumSpecimensAH1N1pdm09DetectSARI.

SARISURVDENOM

Added unknown age cases for hospital catchment population and admissions.

RESPISURV

Similar updates to SARISURV (RSVVacProduct, Drug Used for Prophylaxis, etc.).
Removed antigenic group, date of sample collection, and resistance mutation fields.
Added RSVtype and RSV vaccination variables.

INFLANTIVIR

Updated Influenza AntigenicGroup and GeneticClade multiple times.
Added SequenceID as a new variable.

NCOVVARIANT

Added BA.2.86 (27/11/2023) and KP.3 (29/07/2024) to VirusVariant.

RESPISEVERE

Added InfluenzaTypeSubtype and RSVType.

INFLCLINAGGR

Removed PISA-related variables (Impact, Seriousness, Transmissibility).

Reporting to TESSy

Submission Deadline

Wednesday 23:59 CET for all record types.

Data Preparation

Data can be entered manually or via file upload (CSV/XML).
Ensure data matches the most recent metadata format.

Metadata Compliance

Field formats must be correct (e.g., dates in YYYY-MM-DD format).
Coded values are required for specific fields (e.g., Gender: M, F, UNK, Other).

Submission Process

Use the TESSy / Upload page under EpiPulse > Report > Cases.
Previously reported data can be reviewed on the TESSy / Review page under EpiPulse > Manage > Edit case / Case validation.

Finalising Submission

Data is validated automatically upon upload.
Results are shown on the Validation details page.
If rejected, corrections are required.
If validated, review for possible data quality issues or overwriting existing records.

Record Types Overview

Record Type	Type of Data	Description
INFLCLINAGGR	Aggregated	Weekly age-disaggregated primary care syndromic data (ILI/ARI) and qualitative indicators.
RESPIAGGR	Aggregated	Age-disaggregated lab-confirmed detections and tests from sentinel and non-sentinel systems.
RESPISEVERE	Aggregated	Age-disaggregated hospital, ICU, and death indicators for respiratory illness.
RESPISURV	Case-based	Case-based data for severe respiratory cases not covered by SARI systems.
SARISURV	Case-based	Case-based reporting for SARI cases.
SARISURVDENOM	Aggregated	Weekly denominators for SARI cases (hospital catchment population and admissions).
INFLSARIAGGR	Aggregated	Age-disaggregated SARI data including hospital admissions and deaths.
INFLANTIVIR	Case-based	Strain-based influenza virus characterisation and antiviral susceptibility data.
NCOVVARIANT	Aggregated	Weekly aggregated reporting of SARS-CoV-2 variants of interest and concern (optional if using GISAID).

Key Metadata Fields

Common Fields

RecordId: Unique, anonymous identifier provided by the Member State.
RecordType: Must be RESPIAGGR, RESPISEVERE, or SARISURV.
RecordTypeVersion: Version number for the record type (default set by TESSy).
Subject: Must be RESPIAGGR, RESPISEVERE, or SARISURV.
DataSource: Defined by the National Coordinator.
Status: NEW/UPDATE (default), DELETE for inactive records.
ReportingCountry: ISO 3166-1-alpha-2 code.
DateUsedForStatistics: Format yyyy-Www (e.g., 2025-W01).

Age Groups

Age groups are reported as numeric values, with specific fields for each range (e.g., Age00-04, Age65-79).
AgeUnk is used for unknown age cases.

Indicators

Indicator: Must be TESTS or DETECTIONS.
Surveillance type: STL for sentinel, NONSTL for non-sentinel.
Pathogen: Options include INFL, RSV, SARSCOV2, or O (Other).

Influenza Type/Subtype

Coded values include:
- A, AH3, AH3N2, B, BVic, BYam, AH1pdm09, AH1N1pdm09, UNK.

RSV Type

Coded values include:
- A, B, UNK.

Additional Notes

Case definitions: Only confirmed cases are reported; probable or possible cases are not collected.
WHO Reporting: All data is shared with WHO/Europe weekly.
Help Desk: Contact via TESSy@ecdc.europa.eu or +46-(0)8-5860 1601 (Mon-Fri, 9:00–16:00 CET).
Training: Available on the EpiPulse Cases (TESSy) website.

展开完整摘要